U.S. Household Products Stock News

Why BNY’s new preferred stock moves matter for common shareholders Bank of New York Mellon Corporation (BK) has launched a proposed public offering of Series M Noncumulative Perpetual Preferred Stock via depositary shares, alongside a completed US$500m variable rate preferred fixed income deal. For you as a common shareholder, these preferred moves sit alongside BNY’s push into blockchain settlement, tokenization and AI driven onboarding. Together, they raise questions about capital...

In late February 2026, Trupanion reported its full-year 2025 results, highlighting a return to profitability with net income of US$19.4 million and surpassing US$1.00 billion in annual subscription revenue driven by pricing aligned to rising veterinary costs and improved operating margins. The company also issued an optimistic 2026 outlook, projecting total revenue of about US$1.55–US$1.58 billion and targeting adjusted operating income growth of roughly 19%, while exploring lower-priced...

In recent days, escalating conflict involving Iran and effective disruption around the Strait of Hormuz have pushed global oil prices sharply higher, focusing attention on Exxon Mobil’s large upstream operations. At the same time, Exxon Mobil confirmed that director Jeffrey W. Ubben will not seek re-election at the May 2026 shareholder meeting, though his departure is described as unrelated to the company. These developments highlight how sudden geopolitical supply risks can reinforce the...

Spire (SR) has drawn fresh attention after terminating the certificate of designations for its 5.90% Series A Cumulative Redeemable Perpetual Preferred Stock, along with recent earnings and dividend updates in the natural gas utilities sector. See our latest analysis for Spire. That change to Spire’s capital structure comes as the share price trades at US$91.66, with a 30 day share price return of 8.49% and a 1 year total shareholder return of 22.45%. The 5 year total shareholder return of...

In late February 2026, Pfizer and Astellas reported that PADCEV plus Keytruda cut the risk of tumor recurrence, progression or death in cisplatin-eligible muscle-invasive bladder cancer patients versus standard chemotherapy, while Pfizer also secured full FDA approval for BRAFTOVI-based combination therapy in first-line BRAF V600E-mutant metastatic colorectal cancer. Together, these oncology advances strengthen Pfizer’s presence in high-need cancer settings and may help offset pressure from...

Range Resources (RRC) is back in focus after reporting 2025 results with record operational efficiencies, setting a new 2026 capital plan and production guidance, and lifting its quarterly dividend payout to shareholders. See our latest analysis for Range Resources. The recent earnings beat, operational records and dividend increase appear to be feeding into solid momentum, with a 7 day share price return of 8.6% and a year to date share price return of 18.6%, while the 5 year total...

Bio-Rad Laboratories (BIO) has been drawing attention after a mixed stretch for the share price, with gains over the past year but declines over the past 3 months and year to date. See our latest analysis for Bio-Rad Laboratories. Recent trading has been choppy, with a 4.23% 7 day share price return following a weaker 30 day share price return of a 4.80% decline. A 12.23% decline over 90 days points to fading momentum despite a 9.02% 1 year total shareholder return. If this mixed performance...

Event context and recent share performance Maximus (MMS) has come onto investors’ radar after a period of mixed share performance. The stock is down roughly 22% over the past month and about 15% over the past 3 months. See our latest analysis for Maximus. Against this recent slide, Maximus still has a 1 year total shareholder return of 16.64%. However, the 3 year and 5 year total shareholder returns of 6.02% and 6.59% declines suggest fading longer term momentum. If Maximus’ move has you...

Why Webull’s Recent Performance Has Caught Investor Attention Webull (BULL) has been on many watchlists after a mixed stretch in its share performance, with a 4% gain over the past day and 7.9% over the past week, offset by weaker month and past 3 months returns. At a last close of US$6.04, the digital trading platform shows annual revenue of about US$514.8m alongside a net loss of roughly US$524.7m, which puts profitability front and center for many investors assessing the stock. See our...

Conagra Brands (NYSE:CAG) has added John Mulligan and Pietro Satriano to its board of directors. Mulligan and Satriano bring leadership experience from Target, McDonald's, US Foods, and Loblaw. The appointments signal a focus on retail operations, finance, and foodservice expertise at the board level. Conagra Brands, trading at $19.18, sits in a challenging spot after a 20.8% decline over the past year and a 33.5% decline over five years, even with a 10.9% gain year to date. For investors...

Why the SoFiUSD partnership matters for Mastercard stock Mastercard (MA) is putting stablecoins directly into its core plumbing, partnering with SoFi to let SoFiUSD settle card transactions across its global network and plug into its Multi Token Network. For you as a shareholder or prospective investor, this move brings stablecoin adoption, blockchain based settlement and card network economics into the same conversation. It raises fresh questions about how Mastercard’s business model could...

In February 2026, Centerspace reported fourth-quarter 2025 results showing sales of US$66.62 million and a net loss of US$18.38 million, alongside full-year sales of US$273.66 million and net income of US$17.59 million. The company paired this with 2026 guidance calling for a diluted net loss per share of US$0.49 to US$0.19, signaling a potential step back after returning to profitability in 2025. Next, we’ll examine how Centerspace’s return to profit in 2025 but projected loss in 2026...

Microsoft (MSFT) is back in focus after its fiscal second quarter highlighted strong cloud and AI demand, with commercial bookings and Microsoft Cloud revenue both growing, and new Copilot deployments rolling out across large enterprise and healthcare clients. See our latest analysis for Microsoft. Even with strong AI and cloud headlines, Microsoft’s recent share price tells a different story. The 30 day share price return is 7.4% and the 90 day share price return is 18.7%, while the 1 year...

In recent weeks, Iron Mountain Inc. has seen its short interest fall by 14.69%, with 3.6% of its freely traded shares now sold short, below the peer average of 5.54%. This pullback in bearish positioning suggests a meaningful shift in sentiment, as investors appear relatively more confident in Iron Mountain’s outlook than in many of its peers. With this backdrop of easing short interest, we’ll explore how changing investor sentiment could influence Iron Mountain’s evolving investment...

AXT, Inc. has reported its fourth-quarter 2025 results, with sales of US$23.04 million and a net loss of US$3.55 million, while full-year 2025 sales reached US$88.33 million alongside a net loss of US$21.26 million. The company’s quarterly loss narrowed compared with a year earlier even as full-year losses increased, setting an interesting backdrop for its push into indium phosphide substrates for AI-related infrastructure. We’ll now examine how AXT’s efforts to expand indium phosphide...

Recent downgrades and cautious commentary on Adobe (ADBE), focused on AI driven competitive threats to its seat based software model, have pushed the stock into the spotlight for investors who are reassessing its long term positioning. See our latest analysis for Adobe. Adobe's share price has come under pressure in 2026, with a year to date share price return of 21.73% decline and a 1 year total shareholder return of 41.51% decline, pointing to fading momentum as AI related competition...

What Bank of America’s recent share performance might be telling you Bank of America (BAC) shares have slipped about 6% over the past month and past 3 months, and are down roughly 11% year to date, prompting investors to reassess the stock’s current setup. See our latest analysis for Bank of America. With the share price at US$49.81 after a 6.4% decline over the past month, recent weakness contrasts with a 1 year total shareholder return of 11.9% and a 3 year total shareholder return of...

Trip.com Group Limited recently reported its full-year 2025 results, with revenue rising to CNY 62.41 billion and net income reaching CNY 33.29 billion, while also announcing board changes including the departure of co-founders Min Fan and Qi Ji and the appointment of new independent directors May Yihong Wu and Iris Yang Xiao. These developments came alongside disclosure of an antitrust investigation by China’s market regulator and related shareholder legal scrutiny, placing Trip.com’s...

Navitas Semiconductor (NVTS) has been back in the spotlight after its fourth quarter earnings release, fresh revenue guidance, and plans to showcase new AI focused power semiconductor products at APEC 2026 drew renewed investor attention. See our latest analysis for Navitas Semiconductor. The recent earnings update, new revenue guidance and AI focused product plans have come alongside strong price momentum, with a 7 day share price return of 17.61% and a 1 year total shareholder return above...

Morningstar, Inc. has appointed Scott Brown as President, Direct Platform, effective March 2, 2026, and Morningstar Retirement has launched the Foundation Series multi-manager Collective Investment Trusts in collaboration with Alta Trust Company and nine asset managers to expand access to institutional-quality solutions for retirement plans. Together with recent research and coverage underscoring Morningstar’s role in retirement income guidance and its expanding data and platform...

Helix Energy Solutions Group, Inc. recently reported fourth-quarter and full-year 2025 results showing lower sales and net income year-on-year, alongside a US$18,064,000 long-lived asset impairment and completion of a US$71.49 million share repurchase program that retired 9,094,398 shares since February 2023. As the company now evaluates acquisition opportunities and broader capital deployment, investors may weigh the tension between weaker recent performance and management’s appetite for...

Wondering whether Cigna Group is offering good value at around US$290.85 a share, or if the market is pricing it about right? This article walks through the key valuation angles you will want to consider. The stock has recently been steady to positive, with returns of 2.7% over the past 7 days, 6.1% over the past 30 days and 4.2% year to date, set against a 4.7% decline over the past year and longer term returns of 6.5% over 3 years and 34.8% over 5 years. These moves sit alongside ongoing...

In February 2026, Costamare Inc. reported that fourth-quarter 2025 revenue was US$211.97 million versus US$224.01 million a year earlier, with net income rising to US$80.46 million from US$28.86 million and full-year 2025 net income increasing to US$364.58 million on revenue of US$877.90 million. An interesting twist is that Costamare grew quarterly and full-year net income and basic earnings per share even as both quarterly and annual revenue edged lower year on year. We will now examine...

Recent price performance and business context Geron (GERN) has been moving on mixed recent returns, with a 7.7% decline over the past day and a 12.4% drop over the past week, set against gains over the past month and past 3 months. The stock last closed at US$1.55. The company reports annual revenue of US$183.881 and a net loss of US$85.782, positioning it as a commercial stage oncology player built around its telomerase inhibitor RYTELO for myelodysplastic syndromes. See our latest analysis...